Results 101 to 110 of about 4,754 (217)

Interventions for American cutaneous and mucocutaneous leishmaniasis: a systematic review update.

open access: yesPLoS ONE, 2013
IntroductionLeishmaniasis is an important public health problem in the Americas. A Cochrane review published in 2009 analyzed 38 randomized controlled trials (RCT). We conducted a systematic review to evaluate the effects of therapeutic interventions for
Ludovic Reveiz   +4 more
doaj   +1 more source

Granulomatous rhinitis secondary to feline leishmaniosis: report of an unusual presentation and therapeutic complications

open access: yesJournal of Feline Medicine and Surgery Open Reports, 2018
Case summary A 12-year-old male neutered domestic shorthair cat underwent rhinoscopy due to inspiratory dyspnoea and stertor. Rhinoscopy showed signs of chronic rhinitis and a multinodular nasopharyngeal mucosa.
Rodolfo Oliveira Leal   +5 more
doaj   +1 more source

Advanced Technologies for Oral Controlled Release: Cyclodextrins for oral controlled release [PDF]

open access: yes, 2011
Cyclodextrins (CDs) are used in oral pharmaceutical formulations, by means of inclusion complexes formation, with the following advantages for the drugs: (1) solubility, dissolution rate, stability and bioavailability enhancement; (2) to modify the drug ...
A Al-Omar   +153 more
core   +1 more source

Treatment of Leishmania infantum Infections in Dogs

open access: yesMicroorganisms
Dogs are reservoir hosts of the zoonotic parasite Leishmania infantum, the causative agent of canine leishmaniosis. Antiparasitic drugs that are commonly used in dogs include allopurinol, miltefosine, and meglumine antimoniate.
Melanie Kaempfle   +2 more
doaj   +1 more source

In vitro and in vivo activity of meglumine antimoniate produced at Farmanguinhos-Fiocruz, Brazil, against Leishmania (Leishmania) amazonensis, L (L.) chagasi and L (Viannia) braziliensis

open access: yesMemorias do Instituto Oswaldo Cruz, 2008
The leishmanicidal activity of four batches of meglumine antimoniate, produced in Farmanguinhos-Fiocruz, Brazil (TAMs), was assessed and compared to Glucantime®-Aventis Pharma Ltda.
Eliane de Morais-Teixeira   +6 more
doaj   +1 more source

Treatment of cutaneous leishmaniasis among travellers [PDF]

open access: yes, 2017
Leishmaniasis is endemic in 88 countries on five continents. There are 1-1.5 million cases of cutaneous leishmaniasis reported yearly worldwide. There has been a sharp increase in recorded cases over the last 10 years. Based on geographical distribution,
Beck, B.   +4 more
core  

Topical formulations of miltefosine for cutaneous leishmaniasis in a BALB/c mouse model. [PDF]

open access: yes, 2016
UNLABELLED: Cutaneous leishmaniasis (CL) is caused by several species of the protozoan parasite Leishmania and affects approximately 10 million people worldwide.
Croft, Simon L   +3 more
core   +2 more sources

Treatment of American tegumentary leishmaniasis in special populations: a summary of evidence

open access: yesRevista da Sociedade Brasileira de Medicina Tropical, 2013
We aimed to assess and synthesize the information available in the literature regarding the treatment of American tegumentary leishmaniasis in special populations.
Juliana Saboia Fontenele e Silva   +3 more
doaj   +1 more source

Cost-effectiveness analysis of thermotherapy versus pentavalent antimonials for the treatment of cutaneous leishmaniasis [PDF]

open access: yes, 2018
Introduction: The treatment of cutaneous leishmaniasis is toxic, has contraindications and a high cost. Objective: To estimate the cost-effectiveness of thermotherapy versus pentavalent antimonials for the treatment of cutaneous leishmaniasis. Methods:
Cardona-Arias, Jaiberth Antonio   +3 more
core  

Meglumine Antimoniate and Miltefosine Combined With Allopurinol Sustain Pro-inflammatory Immune Environments During Canine Leishmaniosis Treatment

open access: yesFrontiers in Veterinary Science, 2019
Canine leishmaniosis (CanL) caused by Leishmania infantum is a zoonotic disease of global concern. Antileishmanial drug therapies commonly used to treat sick dogs improve their clinical condition, although when discontinued relapses can occur.
Marcos Ferreira Santos   +16 more
doaj   +1 more source

Home - About - Disclaimer - Privacy